Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9090390 | 0.93 | ACE (0.41) | ACECYP1A2NR1I2CYP2C19 | |
| SCHEMBL9090397 | 0.93 | ACE (0.41) | ACECYP1A2NR1I2CYP2C19 | |
| SCHEMBL10981374 | 0.87 | BCHE (0.40) | NR1I2 | |
| SCHEMBL2674102 | 0.86 | CYP1A2 (0.41) | ACECYP1A2CYP2C19 | |
| SCHEMBL6516948 | 0.86 | CYP1A2 (0.41) | ACECYP1A2CYP2C19 | |
| SCHEMBL5017113 | 0.86 | CYP1A2 (0.41) | ACECYP1A2CYP2C19 | |
| SCHEMBL10818613 | 0.83 | ACE (0.44) | ACECYP1A2NR1I2CYP2C19 | |
| SCHEMBL8674297 | 0.83 | S1PR1 (0.51) | NR1I2 | |
| SCHEMBL5513172 | 0.83 | S1PR1 (0.51) | NR1I2 | |
| SCHEMBL624298 | 0.83 | ACE (0.42) | ACECYP1A2NR1I2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107405278-A | The peptide that sequence is HIS D TRP ALA TRP D PHE LYS NH2 is used to reduce or the novel use of the sign of the appearance of delaying cell aging and skin aging | ISP投资有限公司 | 2017-11-28 | — | — | CN | claimed |
| CN-107337710-A | A kind of antihypertensive active peptide The The Pro and application and pharmaceutical composition | 盐城卫生职业技术学院 | 2017-11-10 | — | — | CN | claimed |
| CN-1503908-A | Enzymatic test for the determination of the risk of pathologies related to the pressure of sialidase or prolidase activity in women body fluid samples | — | 2004-06-09 | — | — | CN | claimed |
| EP-0020290-B1 | PROCESS FOR THE SPECIFIC SPLITTING-OFF OF PROTEIN SEQUENCES FROM PROTEINS | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-07-11 | — | — | EP | claimed |
| WO-2024031031-A2 | COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS | Quantum-Si Incorporated (US) | 2024-02-08 | — | — | WO | disclosed |
| US-20230213527-A1 | COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS | QUANTUM SI INC (US) | 2023-07-06 | — | — | US | disclosed |
| WO-2023122769-A2 | COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS | Quantum-Si Incorporated (US) | 2023-06-29 | — | — | WO | disclosed |
| CN-114401769-A | System and method for producing collagen7 compositions | 菲尼克斯组织修复公司 | 2022-04-26 | — | — | CN | disclosed |
| CN-109714982-A | Flavor is generated in food | 雀巢产品技术援助有限公司 | 2019-05-03 | — | — | CN | disclosed |
| CN-109153983-A | Flavor is generated in food | 雀巢产品技术援助有限公司 | 2019-01-04 | — | — | CN | disclosed |
| CN-107337710-A | A kind of antihypertensive active peptide The The Pro and application and pharmaceutical composition | 盐城卫生职业技术学院 | 2017-11-10 | — | — | CN | disclosed |
| EP-2308901-B1 | Cleavage of fusion proteins using Granzyme B protease | HOFFMANN LA ROCHE (CH) | 2017-11-08 | — | — | EP | disclosed |
| CN-1053098-C | Hair nourishing agent and production thereof | TANISAK LTD (JP) | 2000-06-07 | — | — | CN | disclosed |
| EP-0956297-A1 | CHIRAL PEPTIDE NUCLEIC ACIDS | ISIS INNOVATION LIMITED (GB) | 1999-11-17 | — | — | EP | disclosed |
| WO-1999011799-A2 | HUMAN AMINOPEPTIDASE P GENE | MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE, INC. (US) | 1999-03-11 | — | — | WO | disclosed |
| US-5856166-A | ENDOGENOUS TO STREPTOMYCES CELLS DEGRADES HETEROLOGOUS SECRETED FROM STREPTOMYCES HOST CELL | CANGENE CORPORATION (CA) | 1999-01-05 | — | — | US | disclosed |
| WO-1998016550-A1 | CHIRAL PEPTIDE NUCLEIC ACIDS | ISIS INNOVATION LIMITED (GB) | 1998-04-23 | — | — | WO | disclosed |
| US-5616485-A | GENETIC ENGINEERING | CANGENE CORPORATION (CA) | 1997-04-01 | — | — | US | disclosed |
| CN-1072588-A | Hair nourishing agent and production method thereof | TANISAKE KK (JP) | 1993-06-02 | — | — | CN | disclosed |
| US-4543329-A | GENETIC ENGINEERING, SEPARATION OF FOREIGN AND NATIVE PROTEIN | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-09-24 | — | — | US | disclosed |